Outcome of a de-labelling algorithm compared with results of penicillin (ß-lactam) allergy testing.

ABSTRACT

BACKGROUND: Penicillin allergy labels frequently impede guideline-directed treatment with a penicillin or other ß-lactam antibiotics. Despite presumed allergy, targeted questioning may indicate a low probability of sensitization and permit reasonably safe administration of the antibiotic in question. In this study, we evaluated a standardized algorithm aiming to differentiate non-allergic patients from those with true allergic ß-lactam hypersensitivity. METHODS: We retrospectively applied a de-labelling algorithm in 800 consecutive patients with suspected ß-lactam hypersensitivity. All had undergone complete allergy work-up permitting to definitely exclude or diagnose ß-lactam allergy between 2009 and 2019. RESULTS: In 595 (74.4%) out of 800 cases evaluated, ß-lactam allergy could be excluded by negative challenge testing. IgE-mediated anaphylaxis was diagnosed in 70 (8.7%) patients, delayed-type hypersensitivity in 135 (16.9%). In 62 (88.6%) anaphylaxis cases, the algorithm correctly advised to use an alternative antibiotic. Accuracy was higher in patients with moderate to severe anaphylaxis (97.7%) compared to those with a history of mild reactions (73.1%). The algorithm correctly identified 122 (90.4%) patients with proven delayed-type hypersensitivity. It permitted de-labelling in 330 (55.5%) out of 595 patients with diagnostic exclusion of penicillin hypersensitivity, but failed to identify the remaining 265 (44.5%) as low-risk cases. CONCLUSIONS: The algorithm detected 89.8% of cases with penicillin (ß-lactam) allergy, sensitivity was optimal for moderate to severe anaphylaxis. Study data justify the implementation of a standardized de-labelling algorithm under close supervision in order to permit guideline-directed treatment and reduce the use of broad-spectrum antibiotics as part of an antibiotic stewardship program.